MPA
EW icon

Marvin & Palmer Associates’s Edwards Lifesciences EW Stock Holding History

Marvin & Palmer Associates’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-91,933
Closed -$11.9M – 33
2021
Q4 		$11.9M Sell
91,933
-10,449
-10% -$1.22M 5.1% 7
2021
Q3 		$11.6M Buy
+102,382
New +$11.7M 4.7% 9
2021
Q1 		– Sell
-100,588
Closed -$8.31M – 30
2020
Q4 		$8.31M Buy
100,588
+3,974
+4% +$330K 3.32% 20
2020
Q3 		$7.71M Buy
96,614
+9,803
+11% +$765K 4.07% 10
2020
Q2 		$6M Buy
86,811
+12,351
+17% +$878K 3.62% 14
2020
Q1 		$4.68M Sell
74,460
-14,286
-16% -$1.03M 4.48% 9
2019
Q4 		$6.9M Buy
+88,746
New +$6.93M 4.07% 13

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marvin & Palmer Associates's EW Position: Q1 2022 in Review

Marvin & Palmer Associates sold out of Edwards Lifesciences (EW) in Q1 2022, closing a stake of 91,933 shares — an estimated $11.9M sold.

Marvin & Palmer Associates first reported a position in EW in Q4 2019 and held it in 7 quarters. The position peaked at $11.9M in Q4 2021. 1,312 funds tracked by Wall St. Rank hold EW as of Q1 2022.

  • Marvin & Palmer Associates reported no remaining Edwards Lifesciences position as of Q1 2022 after selling out during the quarter.
  • Marvin & Palmer Associates sold 91,933 Edwards Lifesciences shares in Q1 2022, an estimated $11.9M.
  • Marvin & Palmer Associates first reported a position in Edwards Lifesciences in Q4 2019 and held it in 7 quarters.
  • Marvin & Palmer Associates's Edwards Lifesciences position peaked at $11.9M in Q4 2021.
  • 1,312 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2022.

Based on Marvin & Palmer Associates's 13F filing for Q1 2022, filed 11 May 2022.